The effects of varying exposure to malaria transmission on development of antimalarial antibody responses in preschool children. XVI. Asembo Bay Cohort Project

Journal of Infectious Diseases

Volumn 187, Issue 11, 2003, Pages 1756-1764

  Singer, Lauren M ^a   Mirel, Lisa B ^a   Ter Kuile, Feiko O ^a,b   Branch, OraLee H ^a,e   Vulule, John M ^b   Kolczak, Margarette S ^a   Hawley, William A ^a,b   Kariuki, Simon K ^b   Kaslow, David C ^c,f   Lanar, David E ^d   Lal, Altaf A ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f Vical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEROZOITE SURFACE PROTEIN 1;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DISEASE MARKER; ENVIRONMENTAL EXPOSURE; HUMAN; IMMUNOLOGICAL MONITORING; MALARIA FALCIPARUM; MEDICAL ASSESSMENT; PARASITEMIA; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PRIORITY JOURNAL;

ANIMALS; ANOPHELES; ANTIBODIES, PROTOZOAN; CHILD; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KENYA; MALARIA, FALCIPARUM; MALE; MEROZOITE SURFACE PROTEIN 1; MOSQUITO CONTROL; PARASITEMIA; PLASMODIUM FALCIPARUM; RISK FACTORS;

EID: 0037864214     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/375241     Document Type: Article

References (42)

1. World Health Organization. Malaria fact sheet. 1998: http://www.who.int/inf-fs/en/fact094.html.
2. Bloland PB, Boriga DA, Ruebush TK, et al. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense transmission. II. Descriptive epidemiology of malaria infection and disease among children. Am J Trop Med Hyg 1999; 60:641-8.
3. McElroy PD, Lal AA, Hawley WA, et al. Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. Am J Trop Med Hyg 1999; 61:932-40.
4. Snow RW, Molyneux CS, Warn PA, et al. Infant parasite rates and immunoglobulin M seroprevalence as a measure of exposure to Plasmodium falciparum during a randomized controlled trial of insecticide-treated bed nets on the Kenyan coast. Am J Trop Med Hyg 1996; 55:144-9.
5. Abdulla S, Armstrong-Schellenberg J, Nathan R, et al. Impact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: community cross sectional study. BMJ 2001; 322:270-3.
6. Lengeler C. Insecticide-treated bednets and curtains for preventing malaria. Cochrane Database Syst Rev 2000; 2:CD000363.
7. Snow RW, Marsh K. Will reducing Plasmodium falciparum transmission alter malaria mortality among African children? Parasitol Today 1995; 11:188-90.
8. Trape JF, Rogier C. Combating malaria morbidity and mortality by reducing transmission. Parasitol Today 1996; 12:236-40.
9. Smith T, Beck HP, Kitua A, et al. Age dependence of the multiplicity of Plasmodium falciparum infections and of other malariological indices in an area of high endemicity. Trans R Soc Trop Med Hyg 1999:93(Suppl 1):15-20.
10. Charlwood JD, Smith T, Lyimo E, et al. Incidence of Plasmodium falciparum infection in infants in relation to exposure to sporozoite-infected anophelines. Am J Trop Med Hyg 1998; 59:243-51.
11. Beier JC, Killeen GF, Githure JI. Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. Am J Trop Med Hyg 1999; 61:109-13.
12. McElroy PD, Beier JC, Oster CN, et al. Predicting outcome in malaria: correlation between rate of exposure to infected mosquitoes and level of Plasmodium falciparum parasitemia. Am J Trop Med Hyg 1994; 51:523-32.
13. Snow R, Omumbo JA, Lowe B, et al. Relation between severe malaria morbidity in children and level of Plasmodium falciparum transmission in Africa. Lancet 1997; 349:1650-4.
14. Smith T, Charlwood JD, Kitua AY, et al. Relationships of malaria morbidity with exposure to Plasmodium falciparum in young children in a highly endemic area. Am J Trop Med Hyg 1998; 59:252-7.
15. Smith T, Leuenberger R, Lengeler C. Child mortality and malaria transmission intensity in Africa. Trends Parasitol 2001; 17:145-9.
16. Molineaux L. Malaria and mortality: some epidemiological considerations. Ann Trop Med Parasitol 1997; 91:811-25.
17. Lines J. Severe malaria in children and transmission intensity. Lancet 1997; 350:813.
18. Kitua AY, Urassa H, Wechsler M, et al. Antibodies against Plasmodium falciparum vaccine candidates in infants in an area of intense perennial transmission: relationships with clinical malaria and with entomologic inoculation rates. Parasite Immunol 1999; 21:307-17.
19. Branch OH, Oloo AJ, Nahlen BL, Kaslow D, Lal AA. Anti-merozoite surface protein-1 19-kDa IgG in mother-infant pairs naturally exposed to Plasmodium falciparum: subclass analysis with age, exposure to asexual parasitemia, and protection against malaria. V. The Asembo Bay Cohort Project. J Infect Dis 2000; 181:1746-52.
20. Bloland PB, Ruebush TK, McCormick JB, et al. Longitudinal cohort study of the epidemiology of malaria infections in an area of intense transmission. I. Description of the study site, general methodology, and study population. Am J Trop Med Hyg 1999; 60:635-40.
21. Branch OH, Udhayakumar V, Hightower AH, et al. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kilodalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. Am J Trop Med Hyg 1998; 58:211-9.
22. 19kD) variants secreted from Saccharomyces cerevisiae. Mol Biochem Parasitol 1994; 63:283-5.
23. Qari SH, Shi YP, Goldman IF, Nahlen BL, Tibayrenc M, Lal AA. Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen. Mol Biochem Parasitol 1998; 92:241-52.
24. Udhayakumar V, Anyona D, Kariuki S, et al. Identification of T and B cell epitope recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1. J Immunol 1995; 154:6022-30.
25. Shi Y, Udhayakumar V, Alpers M, et al. Natural antibody responses against the non-repeat-sequence-based B-cell epitopes of the Plasmodium falciparum circumsporozoite protein. Infect Immun 1993; 61:2425-33.
26. Gimnig JG, Kolczak MS, Hightower AW, et al. Effect of permethrin-treated bed nets on the spatial distribution of malaria vectors in western Kenya. Am J Trop Med Hyg 2003; 68:115-20.
27. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS system for mixed model. Cary, NC: SAS Institute, 1996.
28. Singer J. Using SAS proc mixed to fit multilevel models, hierarchical models, and individual growth models. J Educ Behav Stat 1998; 24:323-55.
29. Ter Kuile FO, Terlouw DJ, Kariuki SK, et al. Impact of permethrin-treated bednets on malaria, anemia, and growth in infants in an area of intense perennial malaria transmission in western Kenya. Am J Trop Med Hyg 2003; 68:68-77.
30. Kariuki S, Lal A, Terlouw D, et al. Effects of insecticide-impregnated bednets on immune responses to Plasmodium falciparum antigens in a malaria holoendemic area of western Kenya. I. Antibody responses to pre-erythrocytic and erythrocytic antigens in young children. Am J Trop Med Hyg 2003; 68:108-14.
31. Stoute JA, Slaoui M, Heppner DG, et al. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N Engl J Med 1997; 366:86-91.
32. Snow RW, Shenton FC, Lindsay SW, Greenwood BM. Sporozoite antibodies and malaria in children in a rural area of The Gambia. Ann Trop Med Parasitol 1989; 83:559-68.
33. Genton B, Hill J, Al-Yaman F, et al. The use of untreated bednets and malaria infection, morbidity, and mortality. Ann Trop Med Parasitol 1994; 88:263-70.
34. Askjaer N, Maxwell C, Chambo W, et al. Insecticide-treated bed nets reduce plasma antibody levels and limit repertoire of antibodies to Plasmodium falciparum variant surface antigens. Clin Diagn Lab Immunol 2001; 8:1289-91.
35. Sabchareon A, Burnouf T, Ouattara D, et al. Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg 1991; 45:297-308.
36. Chang SP, Gibson HL, Lee-Ng CT, Barr PJ, Hui GS. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J Immunol 1992; 149:S48-55.
37. Shi Y, Sayed U, Qair S, et al. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. Infect Immun 1996; 64:2716-23.
38. Stirnadel H, Al-Yaman F, Genton B, Alpers M, Smith T. Assessment of different sources of variation in the antibody responses to specific malaria antigens in children in Papua New Guinea. Int J Epidemiol 2000; 29:579-86.
39. Schofield L. The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite? Bull World Health Organ 1990; 68 (Suppl):66-73.
40. Stites DP, Terr AI, Parslow TG, eds. Medical immunology. 9th ed. Stamford, CT: Appleton & Lange, 1997.
41. Schofield L, Uadia P. Lack of ir gene control in the immune response to malaria. J Immunol 1990; 144:2781-8.
42. Wipasa J, Xu H, Stowers A, Good MF. Apoptotic deletion of Th cells specific for the 19-kDa carboxyl-terminal fragment of erozoite surface protein 1 during malaria infection. J Immunol 2001; 167:3903-9.